TGFB1 and glioblastoma: Transforming growth factor-beta (TGF-β), an ECM-bound bioactive factor, is involved in both the activation of NF-κB signaling and mesenchymal transition of GBM (Song et al., 2018; Batlle and Massague, 2019).